About NanoSynex

NanoSynex is a MedTech company that aims at providing new solutions to improve testing quality and reduce healthcare costs by speeding up diagnostic processes.

Today, NanoSynex is focused on the development and commercialization of a rapid innovative Antimicrobial Susceptibility Test (AST). The technology is based on a purely phenotypic approach and uses a microfluidic disposable test card platform and method that optimizes bacterial growth. This disruptive development was born from exciting research discoveries at the lab of Professor Shulamit Levenberg, former Dean of the Technion Institute of Technology – Biomedical Engineering Faculty.

NanoSynex’s team is composed of passionate, dedicated business executives, top-notch biomedical engineers and microbiologist team members and supported by a network of experts, including strategic alliances with future distributors, that know how to bring this revolutionary product to the market.


The current team in place consists of 10+ multidisciplinary individuals with broad experience in all relevant areas to make NanoSynex succeed, including two women co-founders, Diane Abensur and Michelle Heymann, passionate about healthcare and innovation for business applications, that have been working together since NanoSynex creation, complementing each other in different key positions within the company.


Founder & CEO

Expert in Healthcare deals – worked as a consultant in the healthcare division at Natixis, CGI Business Consulting, and as an analyst in M&A at Tegris Advisors with a focus on healthcare deals. Is NanoSynex CEO since 2017. Was selected in the 2020 edition of the Tech 30 under 30 Forbes list.


Founder & COO

Expert in Healthcare & Science communication – worked in the Brazilian leading newspaper, Folha de S. Paulo, covering Health & Science news. Is NanoSynex COO since 2017. Was selected in the 2020 edition of the Tech 30 under 30 Forbes list.



Seasoned medical device engineer with over 20 years of experience. Has a proven track record of developing complex multi-disciplinary medical technologies from feasibility & proof of concept through product development to commercialization.

Prof. Shulamit

Chief Scientific Officer (CSO)

Former Dean of the Technion Institute of Technology – Biomedical Engineering Faculty, rewarded inventor of NanoSynex’score technology, +80 peer-reviewed articles.


System Engineer

Expert in biotechnologies and microfluidic, previous expertise in assay development for improvement of therapeutic processes.

Dr. Jonathan

Scientist & Inventor

Expert in NanoSynex’s core technology for medical applications and inventor (during his Ph.D in Biomedical Engineering at the Technion).


Hardware Manager

Expert in multidisciplinary hardware development, from scratch to fully integrated and scaled-up systems with 20 years of experience.



International experience in clinical and diagnostic microbiology in hospital settings, including 6 years in Infection Prevention and Control, and startup experience as R&D scientist in assay development.


System Engineer

Scientist and Engineer, with 15 years of global experience in drug and diagnostic/ medical devices development.


Biomedical Engineer

Biomedical Engineer, specializing in implementation of fluidic concepts towards medical device development.

Advisory board & Kol

The company also counts with more than seven key experts consultants, including :

Dr. Yuval

Scientific Advisor

Director of the Maccabi Northern Megalab (incl. all Clinical Labs) and former director of Clinical Microbiology Lab, Rambam Hospital, IL

Dr. Marc

Scientific Advisor

Director of Microbiology and Immunology Lab, Shaare Zedek Hospital, IL

Dr. Jonathan

Scientific Advisor

Former head of the National Institute for Antibiotic Resistance & Infection Control Ministry of Health (IL) and current head of the Clinical Laboratories department (incl. the Microbiology lab) at Laniado, IL

Dr. Natan

Scientific Advisor

Former Director of the Department of Clinical Microbiology at the Sheba Medical Center, IL, and current chairman of the IRB

Dr. Claude-James

Scientific Advisor

Professor Emeritus at the Faculty of the Medicine of Creteil (Paris, France), and previous head of the Bacteriology-Virology division at the Henri-Mondor Hospital (Paris, France). Former EUCAST steering committee member


Industry Expert, R&D and strategic Advisor

Founder and former president and CEO LeukoDx (now Accellix)


First place winners of “Suzhou Medtech Global Competition”, organized by TechCode (received a $4K cash prize and a fully subsidized trip to China to join the competition finals and meet potential partners)

Second place winners of “the Shenzhen Innovation and Entrepreneurship International Competition” (received a RMB 130K – ~$18K – cash prize and a fully subsidized trip to China to join the competition finals and meet potential partners)

Winner of the PITCH#5 MEDTECH BOOTCAMP INVESTOR EVENT Received in-kind investment: free legal and professional service providers, partners of the bootcamp
MassChallenge 2017 Class Finalists. Received in-kind investment: free consulting and coaching from Life Science industry and investors experts; free IP review and office space.
SheLovesTech Israeli Finalist